Ascom Holding AG (0QON)
London Stock Exchange · UK · prices in GBP · close of 26 Oct 2026
Key indicators
| Last close | GBP 5.780 |
|---|---|
| 52-week range | 3.338 – 6.705 |
| Return, 1 month / 3 months | −0.2% / +9.6% |
| Return, 1 year / 3 years | +58.6% / −37.8% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 41.7% |
| Worst drawdown (1 year) | -23.1% |
| Average daily value traded | 0.05M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ascom Holding AG is a Swiss technology company based in Baar that supplies communication and information systems for healthcare providers. Its products include nurse call systems, clinical alarm management, mobile devices for caregivers and software that helps hospitals coordinate staff and respond to patient needs. Customers are mainly hospitals, clinics and other care facilities, chiefly in Europe and other markets where it operates through local subsidiaries and partners.
On this site Ascom Holding AG appears as a stock on the London Stock Exchange (UK), code 0QON, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ascom Holding AG (0QON) trades on the London Stock Exchange in UK. It last closed at GBP 5.780 on 26 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,596 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.6% and over the last three months it rose 9.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.8% | ||
| From 52-week high | -12.2% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.6% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | 58.9% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.1% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | −0.2% |
| 3 months | +9.6% |
| 6 months | +11.0% |
| 1 year | +58.6% |
| 3 years | −37.8% |
| 5 years | −60.1% |
Signals
| 50-day / 200-day average | 5.600 / 5.516 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.111 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | GBX 0.0020 |
| 22 Apr 2025 | GBX 0.0010 |
| 18 Apr 2024 | GBX 0.0030 |
| 20 Apr 2023 | GBX 0.0020 |
| 19 Apr 2022 | GBX 0.0020 |
| 12 Apr 2019 | GBX 0.0045 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.